Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single versus double-dose aspirin and platelet function in type 2 diabetes
ISRCTN34087526Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised trial of aspirin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Oxford. Primary endpoint: Change in platelet reactivity between baseline and the end of each treatment period. Started Nov 2011; status: completed.
02
Drugs
aspirin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN34087526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN34087526.